Last quarter (Q ), Kraig Biocraft Laboratories's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Kraig Biocraft Laboratories's net income was $-1.32M. See Kraig Biocraft Laboratories’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 1.64M	$ 2.61M	$ 2.12M	$ 7.46M	$ 4.53M	$ 2.62M
Operating Income	$ -1.64M	$ -2.61M	$ -2.12M	$ -7.46M	$ -4.53M	$ -2.62M
Net Non Operating Interest Income Expense	$ 33.35K	-	$ -153.96K	$ -13.00K	$ -437.13K	$ -287.98K
Other Income Expense	$ -22.63K	$ -55.98K	$ -38.00	$ -90.10K	-	-
Pretax Income	$ -3.03M	$ -3.03M	$ -3.84M	$ -8.05M	$ -4.97M	$ -2.91M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.06M	$ -3.03M	$ -3.84M	$ -8.05M	$ -4.97M	$ -2.91M
Basic EPS	-	-	-	$ -0.01	$ -0.01	$ >-0.01
Diluted EPS	-	-	-	$ -0.01	$ -0.01	$ >-0.01
Basic Average Shares	$ 4.13B	$ 1.03B	$ 974.31M	$ 877.61M	$ 848.65M	$ 835.59M
Diluted Average Shares	$ 4.13B	$ 1.03B	$ 974.31M	$ 877.61M	$ 848.65M	$ 835.59M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	$ 13.09K	$ 14.79K
Total Expenses	$ 1.64M	$ 2.61M	$ 2.12M	$ 7.46M	$ 4.53M	$ 2.62M
Net Income From Continuing And Discontinued Operation	$ -3.03M	$ -3.03M	$ -3.84M	$ -8.05M	$ -4.97M	$ -2.91M
Normalized Income	$ -1.79M	$ -2.22M	$ -2.95M	-	$ -4.97M	$ -2.91M
Interest Expense	-	-	-	-	$ 437.13K	$ 294.35K
EBIT	$ -2.55M	$ -2.55M	$ -3.08M	$ -7.62M	$ -4.53M	$ -2.62M
EBITDA	$ -2.52M	$ -2.52M	$ -1.94M	$ -2.88M	$ -4.51M	$ -2.58M

Currency in USD

Kraig Biocraft Laboratories Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing